NSL-95317

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNSL-95317
Drug Alias NameNSL-95300NSL-95317
ClassificationSmall molecules
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonistsPlatelet aggregation inhibitors
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsThrombosisThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Steel Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Steel Corp
Active IndicationsN/A
Inactive IndicationsThrombosisThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A